Pulmonx Corporation

NasdaqGS:LUNG Stock Report

Market Cap: US$261.0m

Pulmonx Balance Sheet Health

Financial Health criteria checks 6/6

Pulmonx has a total shareholder equity of $93.9M and total debt of $37.2M, which brings its debt-to-equity ratio to 39.6%. Its total assets and total liabilities are $167.4M and $73.5M respectively.

Key information

39.6%

Debt to equity ratio

US$37.24m

Debt

Interest coverage ration/a
CashUS$107.78m
EquityUS$93.93m
Total liabilitiesUS$73.48m
Total assetsUS$167.40m

Recent financial health updates

Recent updates

Not Many Are Piling Into Pulmonx Corporation (NASDAQ:LUNG) Stock Yet As It Plummets 27%

Oct 22
Not Many Are Piling Into Pulmonx Corporation (NASDAQ:LUNG) Stock Yet As It Plummets 27%

Is Pulmonx (NASDAQ:LUNG) Using Debt In A Risky Way?

Oct 02
Is Pulmonx (NASDAQ:LUNG) Using Debt In A Risky Way?

Pulmonx Corporation (NASDAQ:LUNG) Stock's 26% Dive Might Signal An Opportunity But It Requires Some Scrutiny

Aug 15
Pulmonx Corporation (NASDAQ:LUNG) Stock's 26% Dive Might Signal An Opportunity But It Requires Some Scrutiny

Pulmonx: Low Bar For Q2 Earnings

Jul 21

Slammed 26% Pulmonx Corporation (NASDAQ:LUNG) Screens Well Here But There Might Be A Catch

Jun 07
Slammed 26% Pulmonx Corporation (NASDAQ:LUNG) Screens Well Here But There Might Be A Catch

Pulmonx Corporation's (NASDAQ:LUNG) Share Price Matching Investor Opinion

Apr 04
Pulmonx Corporation's (NASDAQ:LUNG) Share Price Matching Investor Opinion

Pulmonx: Revisiting Thesis Following Management Change

Mar 26

Pulmonx (NASDAQ:LUNG) Has Debt But No Earnings; Should You Worry?

Feb 23
Pulmonx (NASDAQ:LUNG) Has Debt But No Earnings; Should You Worry?

Market Participants Recognise Pulmonx Corporation's (NASDAQ:LUNG) Revenues

Aug 01
Market Participants Recognise Pulmonx Corporation's (NASDAQ:LUNG) Revenues

Analysts Just Shaved Their Pulmonx Corporation (NASDAQ:LUNG) Forecasts Dramatically

Nov 08
Analysts Just Shaved Their Pulmonx Corporation (NASDAQ:LUNG) Forecasts Dramatically

Pulmonx GAAP EPS of -$0.40 in-line, revenue of $14M beats by $0.23M

Aug 02

Pulmonx: Interesting Technology But Struggling With Adoption

Jul 02

These Analysts Just Made A Meaningful Downgrade To Their Pulmonx Corporation (NASDAQ:LUNG) EPS Forecasts

Feb 28
These Analysts Just Made A Meaningful Downgrade To Their Pulmonx Corporation (NASDAQ:LUNG) EPS Forecasts

Financial Position Analysis

Short Term Liabilities: LUNG's short term assets ($140.9M) exceed its short term liabilities ($18.3M).

Long Term Liabilities: LUNG's short term assets ($140.9M) exceed its long term liabilities ($55.2M).


Debt to Equity History and Analysis

Debt Level: LUNG has more cash than its total debt.

Reducing Debt: LUNG's debt to equity ratio has reduced from 371% to 39.6% over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: LUNG has sufficient cash runway for more than 3 years based on its current free cash flow.

Forecast Cash Runway: LUNG has sufficient cash runway for more than 3 years if free cash flow continues to reduce at historical rates of 9.9% each year


Discover healthy companies